A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
Verstovsek, Srdan, Mesa, Ruben A, Gotlib, Jason, Levy, Richard S, Gupta, Vikas, DiPersio, John F, Catalano, John V, Deininger, Michael, Miller, Carole, Silver, Richard T, Talpaz, Moshe, Winton, Elliott F, Harvey, Jimmie H, Arcasoy, Murat O, Hexner, Elizabeth, Lyons, Roger M, Paquette, Ronald, Raza, Azra, Vaddi, Kris, Erickson-Viitanen, Susan, Koumenis, Iphigenia L, Sun, William, Sandor, Victor, Kantarjian, Hagop M
Published in The New England journal of medicine (01.03.2012)
Published in The New England journal of medicine (01.03.2012)
Get full text
Journal Article
Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial
Verstovsek, Srdan, Mesa, Ruben A, Gotlib, Jason, Gupta, Vikas, DiPersio, John F, Catalano, John V, Deininger, Michael W N, Miller, Carole B, Silver, Richard T, Talpaz, Moshe, Winton, Elliott F, Harvey, Jr, Jimmie H, Arcasoy, Murat O, Hexner, Elizabeth O, Lyons, Roger M, Paquette, Ronald, Raza, Azra, Jones, Mark, Kornacki, Deanna, Sun, Kang, Kantarjian, Hagop
Published in Journal of hematology and oncology (22.02.2017)
Published in Journal of hematology and oncology (22.02.2017)
Get full text
Journal Article
CHAMPION-1: a phase 1/2 study of once-weekly carfilzomib and dexamethasone for relapsed or refractory multiple myeloma
Berenson, James R., Cartmell, Alan, Bessudo, Alberto, Lyons, Roger M., Harb, Wael, Tzachanis, Dimitrios, Agajanian, Richy, Boccia, Ralph, Coleman, Morton, Moss, Robert A., Rifkin, Robert M., Patel, Priti, Dixon, Sandra, Ou, Ying, Anderl, Janet, Aggarwal, Sanjay, Berdeja, Jesus G.
Published in Blood (30.06.2016)
Published in Blood (30.06.2016)
Get full text
Journal Article
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
Kuter, David J, Prof, Bussel, James B, MD, Lyons, Roger M, MD, Pullarkat, Vinod, MD, Gernsheimer, Terry B, MD, Senecal, Francis M, MD, Aledort, Louis M, MD, George, James N, MD, Kessler, Craig M, MD, Sanz, Miguel A, MD, Liebman, Howard A, MD, Slovick, Frank T, MD, de Wolf, J Th M, MD, Bourgeois, Emmanuelle, MD, Guthrie, Troy H, MD, Newland, Adrian, MA, Wasser, Jeffrey S, MD, Hamburg, Solomon I, MD, Grande, Carlos, MD, Lefrère, François, MD, Lichtin, Alan Eli, MD, Tarantino, Michael D, MD, Terebelo, Howard R, DO, Viallard, Jean-François, MD, Cuevas, Francis J, MD, Go, Ronald S, MD, Henry, David H, MD, Redner, Robert L, MD, Rice, Lawrence, MD, Schipperus, Martin R, MD, Guo, D Matthew, PhD, Nichol, Janet L, MS
Published in The Lancet (British edition) (02.02.2008)
Published in The Lancet (British edition) (02.02.2008)
Get full text
Journal Article
AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITP
Bussel, James B, Kuter, David J, George, James N, McMillan, Robert, Aledort, Louis M, Conklin, George T, Lichtin, Alan E, Lyons, Roger M, Nieva, Jorge, Wasser, Jeffrey S, Wiznitzer, Israel, Kelly, Reggie, Chen, Chien-Feng, Nichol, Janet L
Published in The New England journal of medicine (19.10.2006)
Published in The New England journal of medicine (19.10.2006)
Get full text
Journal Article
Hematologic Response to Three Alternative Dosing Schedules of Azacitidine in Patients With Myelodysplastic Syndromes
LYONS, Roger M, COSGRIFF, Thomas M, MODI, Sanjiv S, GERSH, Robert H, HAINSWORTH, John D, COHN, Allen L, MCINTYRE, Heidi J, FERNANDO, Indra J, BACKSTROM, Jay T, BEACH, C. L
Published in Journal of clinical oncology (10.04.2009)
Published in Journal of clinical oncology (10.04.2009)
Get full text
Journal Article
Phase II Study of Clofarabine Monotherapy in Previously Untreated Older Adults With Acute Myeloid Leukemia and Unfavorable Prognostic Factors
KANTARJIAN, Hagop M, ERBA, Harry P, PETERSDORF, Stephen, SHAMI, Paul J, YEAGER, Andrew M, ECKERT, Stephen, ABICHANDANI, Rekha, FADERL, Stefan, CLAXTON, David, ARELLANO, Martha, LYONS, Roger M, KOVASCOVICS, Tibor, GABRILOVE, Janice, CRAIG, Michael, DOUER, Dan, MARIS, Michael
Published in Journal of clinical oncology (01.02.2010)
Published in Journal of clinical oncology (01.02.2010)
Get full text
Journal Article
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials
Prins, Martin H, Lensing, Anthonie W A, Brighton, Tim A, Lyons, Roger M, Rehm, Jeffrey, Trajanovic, Mila, Davidson, Bruce L, Beyer-Westendorf, Jan, Pap, Ákos F, Berkowitz, Scott D, Cohen, Alexander T, Kovacs, Michael J, Wells, Philip S, Prandoni, Paolo
Published in The Lancet. Haematology (01.10.2014)
Published in The Lancet. Haematology (01.10.2014)
Get more information
Journal Article
Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial
Raskob, Gary E, van Es, Nick, Segers, Annelise, Angchaisuksiri, Pantep, Oh, Doyeun, Boda, Zoltan, Lyons, Roger M, Meijer, Karina, Gudz, Ivan, Weitz, Jeffrey I, Zhang, George, Lanz, Hans, Mercuri, Michele F, Büller, Harry R
Published in The Lancet. Haematology (01.08.2016)
Published in The Lancet. Haematology (01.08.2016)
Get more information
Journal Article
Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia
KANTARJIAN, Hagop, FENAUX, Pierre, SHAMMO, Jamile, SIEGEL, Robert, KUOLUNG HU, FRANKLIN, Janet, BERGER, Dietmar P, SEKERES, Mikkael A, BECKER, Pamela S, BORUCHOV, Adam, BOWEN, David, HELLSTROM-LINDBERG, Eva, LARSON, Richard A, LYONS, Roger M, MUUS, Petra
Published in Journal of clinical oncology (20.01.2010)
Published in Journal of clinical oncology (20.01.2010)
Get full text
Journal Article
In-class transition (iCT) of proteasome inhibitor-based therapy: a community approach to multiple myeloma management
Rifkin, Robert M., Girnius, Saulius K., Noga, Stephen J., Birhiray, Ruemu E., Kambhampati, Suman, Manda, Sudhir, Lyons, Roger M., Yimer, Habte A., Cherepanov, Dasha, Lloyd, Eric, Whidden, Presley, Richter, Joshua
Published in Blood cancer journal (New York) (19.09.2023)
Published in Blood cancer journal (New York) (19.09.2023)
Get full text
Journal Article
A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide
Wang, Eunice S, Lyons, Roger M, Larson, Richard A, Gandhi, Sunil, Liu, Delong, Matei, Carmen, Scott, Bart, Hu, Kuolung, Yang, Allen S
Published in Journal of hematology and oncology (29.11.2012)
Published in Journal of hematology and oncology (29.11.2012)
Get full text
Journal Article
Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method
Cuker, Adam, Despotovic, Jenny M., Grace, Rachael F., Kruse, Caroline, Lambert, Michele P., Liebman, Howard A., Lyons, Roger M., McCrae, Keith R., Pullarkat, Vinod, Wasser, Jeffrey S., Beenhouwer, David, Gibbs, Sarah N., Yermilov, Irina, Broder, Michael S.
Published in Research and practice in thrombosis and haemostasis (01.01.2021)
Published in Research and practice in thrombosis and haemostasis (01.01.2021)
Get full text
Journal Article
Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP
Bussel, James B., Kuter, David J., Pullarkat, Vinod, Lyons, Roger M., Guo, Matthew, Nichol, Janet L.
Published in Blood (05.03.2009)
Published in Blood (05.03.2009)
Get full text
Journal Article
Oral ezatiostat HCl (Telintra®, TLK199) and idiopathic chronic neutropenia (ICN): a case report of complete response of a patient with G-CSF resistant ICN following treatment with ezatiostat, a glutathione S-transferase P1-1 (GSTP1-1) inhibitor
Lyons, Roger M, Wilks, Sharon T, Young, Shelby, Brown, Gail L
Published in Journal of hematology and oncology (02.11.2011)
Published in Journal of hematology and oncology (02.11.2011)
Get full text
Journal Article
Long‐term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
Kuter, David J., Bussel, James B., Newland, Adrian, Baker, Ross I., Lyons, Roger M., Wasser, Jeffrey, Viallard, Jean‐Francois, Macik, Gail, Rummel, Mathias, Nie, Kun, Jun, Susie
Published in British journal of haematology (01.05.2013)
Published in British journal of haematology (01.05.2013)
Get full text
Journal Article
Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long‐term safety and efficacy
Fenaux, Pierre, Muus, Petra, Kantarjian, Hagop, Lyons, Roger M., Larson, Richard A., Sekeres, Mikkael A., Becker, Pamela S., Orejudos, Amelia, Franklin, Janet
Published in British journal of haematology (01.09.2017)
Published in British journal of haematology (01.09.2017)
Get full text
Journal Article
Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin
Davidson, Bruce L, Verheijen, Sara, Lensing, Anthonie W A, Gebel, Martin, Brighton, Timothy A, Lyons, Roger M, Rehm, Jeffrey, Prins, Martin H
Published in JAMA internal medicine (01.06.2014)
Published in JAMA internal medicine (01.06.2014)
Get more information
Journal Article
Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)
Raza, Azra, Galili, Naomi, Mulford, Deborah, Smith, Scott E, Brown, Gail L, Steensma, David P, Lyons, Roger M, Boccia, Ralph, Sekeres, Mikkael A, Garcia-Manero, Guillermo, Mesa, Ruben A
Published in Journal of hematology and oncology (30.04.2012)
Published in Journal of hematology and oncology (30.04.2012)
Get full text
Journal Article